latest update:
[TrialBase DB]

trial summary · NCT07473700

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

An Open-Label Study to Assess the Hemodynamic Effect and the Safety of TX000045 After 16 Weeks of Treatment in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

Trial record from the TrialBase DB dataset, status RECRUITING, condition Hypertension, Pulmonary, sponsored by Tectonic Operating Company, Inc.. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07473700phase PHASE2enrollment 25start 2026-10-30

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

The primary purpose of this study is to assess the effect of TX000045 on pulmonary vascular resistance (PVR) in participants with pulmonary hypertension secondary to interstitial lung disease (PH-ILD) and to assess the safety and tolerability of TX000045 in participants with PH-ILD.

Source record: https://clinicaltrials.gov/study/NCT07473700

Facts

registry idNCT07473700
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE2
study typeINTERVENTIONAL
lead conditionHypertension, Pulmonary
sponsorTectonic Operating Company, Inc.
sponsor classINDUSTRY
enrollment25
start date2026-10-30
primary completion2027-11-21
completion2027-12-11
results postednot reported

Conditions

  • Hypertension, Pulmonary
  • Lung Diseases, Interstitial

Interventions

  • TX000045

Countries

  • Poland
  • Romania
  • Serbia
  • South Korea
  • Spain
  • United States

Intervention types: DRUG

Work with this record